Telavancin: a new lipolycopeptide for Gram-positive infections.
págs. 159-173
Romiplostim: a second-generation thrombopoietin agonist.
págs. 175-188
págs. 189-197
págs. 199-211
Levocetirizine: from scientific evidence to a potent modern-day treatment of today's allergic patients.
págs. 213-225
Inflammatory bowel disease: complications and extraintestinal manifestations.
págs. 227-241
© 2001-2024 Fundación Dialnet · Todos los derechos reservados